Cipla announced that its wholly owned subsidiary Cipla Medpro South Africa (Pty) has signed an agreement on 30 March 2017 to acquire 100% stake in Anmarate (Pty), South Africa.

The transaction is expected to be completed before 14 April 2017, with the deal thought to be worth around ZAR 26 million (USD 2 million).

Anmarate was incorporated in 1996 in South Africa and is engaged in manufacturing and distribution of pharmaceutical products.